Journals / Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2017 / Cilt: 57 - Sayı: 2

A Rare Case Report: Synchronous Pancreatic Ductal Adenocarcinoma and Thyroid Medullary Carcinoma

Nadir Bir Olgu Sunumu: Senkron Pankreatik Duktal Adenokarsinom ve Tiroid Medüller Karsinom

Pages
107–111
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The goal of this report is to share our experience.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Due to advancements in modern medicine, the survival rate for cancer patients has increased.
📊
Key Findings & Data:The occurrence of 2 or more primary tumors in the same patient has thus also increased.
💡
Conclusion & Impact:The goal of this report is to share our experience.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Due to advancements in modern medicine, the survival rate for cancer patients has increased. The occurrence of 2 or more primary tumors in the same patient has thus also increased. Synchronous ductal pancreas adenocarcinoma and thyroid medullary carcinoma was found in a 52-year-old male patient presenting at our hospital. Occurrence of these tumors simultaneously has never been reported. The goal of this report is to share our experience.

Özet

Günümüzde ilerleyen tedavi yöntemleriyle kanserli hastaların sağ kalım süresi uzamıştır. Bu nedenle ikincil primer tümör görülme sıklığında artış gözlenmektedir. Hastanemize başvuran 52 yaşındaki erkek hastada senkron pankreas duktal adenokarsinomu ve tiroid medüller karsinom tespit edildi. Bu iki tümör birlikteliği daha önce bildirilmediğinden literatürde paylaşmayı amaçladık.

🔖

Cite This Article

GÖRET, C. C., AKGÜN, M. Y., ÖZKAN, Ö. F. (2022). A Rare Case Report: Synchronous Pancreatic Ductal Adenocarcinoma and Thyroid Medullary Carcinoma. Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 57 - Sayı: 2, 107–111. https://ajindex.com/articles/535239

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Çeldir Emre J, Baysak A, Çok G, Çağırıcı U. Second Primary Neuroendocrine Tumor in a Patient Operated Because of Lung Carcinoid Tumor: Small Cell Lung Cancer. J Clin Anal Med 2013;4:178-80
  2. Van Leeuwen FE, Travis LB. Second cancers. In: De Vita VT, Hellman S, Rosenberg SA, editors. Cancer, Pirinciples and Practice of Oncology, 6th ed. Philadelphia: Lippincott-Williams&Wilkins; 2001. p. 2939-64
  3. Cibas ES, Ali ZS. The Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol 2009;132:658-65
  4. Tachimori Y. Cancer screening in patients with cancer. Jpn J Clin Oncol 2002;32:118-9
  5. Artac M, Bozcuk H, Ozdogan M, Demiral AN, Sarper A, Samur M, et al. Different clinical features of primary and secondary tumors in patients with multiple malignancies. Tumori 2005;91:317-20
  6. Demandante CG, Troyer DA, Miles TP. Multiple primary malignant neoplasms: case report and a comprehensive review of the literature. Am J Clin Oncol 2003;26:79-83
  7. Crocetti E, Arniani S, Buiatti E. Synchronous and metachronous diagnosis of multiple primary cancers. Tumori 1998;84:9-13
  8. Hemminki K, Boffetta P. Multiple primary cancers as clues to environmental and heritable causes of cancer and mechanisms of carcinogenesis. IARC Sci Publ 2004:289-97
  9. Carey TE. Field cancerization: are multiple primary cancers monoclonal or polyclonal? Ann Med 1996;28:183-8
  10. Dong C, Hemminki K. Multiple primary cancers of the colon, breast and skin (melanoma) as models for polygenic cancers. Int J Cancer 2001;92:883-7
  11. Gököz Doğu G, Yenen A, Yapar Taşköylü B, İşler K, Değirmencioğlu S. Synchronous and metachronous double primary cancer patients: single center experience. Pam Med J 2012;5:1-4
  12. Armakolas N, Armakolas A, Antonopoulos A, Dimakakos A, Stathaki M, Koutsilieris M. The role of the IGF-1 Ec in myoskeletal system and osteosarcoma pathophysiology. Crit Rev Oncol Hematol 2016;108:137-45
  13. Fraumeni JF Jr, Curtis RE, Edwards BK. Introduction. In: Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, et al, editors. New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000. Bethesda, MD: National Cancer Institute; 2006. p. 1-9
  14. Kilic MO, Turkan A, Bozer M, Arslan N, Koktener A. Synchronous tumors: clear cell carcinoma of pancreas and gastrointestinal stromal tumor of stomach. J Turgut Ozal Med Cent 2016;23:306-8
  15. Tavusbay C, Sarı E, Kar H, Gür EÖ, Hacıyanlı M, Ekinci N. Synchronous Gastric and Rectal Cancer: Case Report. Kolon R